iCMLf Conversation: CML Highlights of ASH 2022 - Clinical overview
Автор: International CML Foundation
Загружено: 2023-03-06
Просмотров: 145
Описание:
Expert:
Professor Michael Mauro
Leader of the Myeloproliferative Neoplams Program at the Memorial Sloan Kettering Cancer Centre / Professor of Clinical Medicine at the Weill Cornell Medical College, New York (USA)
Program:
Overview of significant clinical aspects presented during the meeting, including:
00:00 Introduction
00:51 ASCIMINIB
ASCEND Study
ASC4More Study
04:49 Olverembatinib
Olverembatinib in patients with T315I mutation
Olverembatinib in resistant CML
08:32 Vodobatinib phase 1 Study
11:35 Dasatinib, PEG-INF, Ponatinib
Long-term low-dose Dasatinib frontline in CML
ENDURE Study: PEG-INF after discontinuation
OPTIC Trial: Optimization of Ponatinib in different doses
18:28 Non-ABL Myeloid Mutations
22:16 TFR, Race/ethnicity, AP-CML and BC-CML
TFR-PRO Observational Study
Survival by race/ethnicity
2nd generation TKI vs Imatinib in AP-CML
BC-CML Registry
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
